China Bans Posing As Health Experts, Patients In Drug Commercials
This article was originally published in PharmAsia News
Executive Summary
China has issued an edict banning certain types of broadcast advertising and non-professional hosts of medical programs. China's State FDA, Health Ministry and other affected agencies sent out a circular to radio and television stations detailing the ban. They said it was prompted by the discovery of one actor posing as a health expert on TV programs for the purpose of selling drugs while others posed as patients. The new ban bars those types of imitations and says actors and celebrities are not to host medical programs. (Click here for more
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.